These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 36111007)
1. Analysis of m6A-related signatures associated with the tumor immune microenvironment and predict survival in acute myeloid leukemia. Yuan S; Cong Z; Ji J; Zhu L; Jiang Q; Zhou Y; Shen Q; Damiani D; Xu X; Li B Ann Transl Med; 2022 Aug; 10(16):902. PubMed ID: 36111007 [TBL] [Abstract][Full Text] [Related]
2. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia. Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
5. Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes. Wang Y; Bin T; Tang J; Xu XJ; Lin C; Lu B; Sun TT Front Immunol; 2023; 14():1268090. PubMed ID: 38077322 [TBL] [Abstract][Full Text] [Related]
6. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma. Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K Front Immunol; 2021; 12():637933. PubMed ID: 33746977 [TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
8. Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration. Zheng G; Liu M; Chang X; Cao X; Dong A; Zhu H; Hu W; Xie J; Zhao Y; Hu D; Jia X; Yang Y; Shi X; Lu J Front Genet; 2022; 13():888173. PubMed ID: 35601490 [TBL] [Abstract][Full Text] [Related]
9. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment. Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861 [TBL] [Abstract][Full Text] [Related]
10. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia. Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365 [No Abstract] [Full Text] [Related]
11. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia. Zhang L; Ke W; Hu P; Li Z; Geng W; Guo Y; Song B; Jiang H; Zhang X; Wan C Front Genet; 2022; 13():804614. PubMed ID: 35615374 [No Abstract] [Full Text] [Related]
12. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer. Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433 [TBL] [Abstract][Full Text] [Related]
13. N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer. Zhang Y; Zhu B; He M; Cai Y; Ying X; Jiang C; Ji W; Zeng J Front Oncol; 2021; 11():710767. PubMed ID: 34458149 [TBL] [Abstract][Full Text] [Related]
14. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer. Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046 [TBL] [Abstract][Full Text] [Related]
15. RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer. Mu LX; Shao YC; Wei L; Chen FF; Zhang JW Front Genet; 2021; 12():650499. PubMed ID: 35095993 [No Abstract] [Full Text] [Related]
16. m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia. Xu ZJ; Wen XM; Zhang YC; Jin Y; Ma JC; Gu Y; Chen XY; Xia PH; Qian W; Lin J; Qian J Front Genet; 2022; 13():948079. PubMed ID: 36035161 [TBL] [Abstract][Full Text] [Related]
17. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia. Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q Front Immunol; 2021; 12():789914. PubMed ID: 34887874 [TBL] [Abstract][Full Text] [Related]
18. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
19. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer. Liu Y; Wang T; Fang Z; Kong J; Liu J J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma. Chen D; Guo W; Yu H; Yang J Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]